Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.4 EUR | +1.08% | +1.08% | +34.67% |
Sales 2024 * | 4M 4.31M | Sales 2025 * | 4.4M 4.74M | Capitalization | 108M 116M |
---|---|---|---|---|---|
Net income 2024 * | -29M -31.24M | Net income 2025 * | -29M -31.24M | EV / Sales 2024 * | 32.6 x |
Net Debt 2024 * | 22.5M 24.24M | Net Debt 2025 * | 53.7M 57.85M | EV / Sales 2025 * | 36.7 x |
P/E ratio 2024 * |
-3.65
x | P/E ratio 2025 * |
-3.61
x | Employees | 56 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 55.48% |
Latest transcript on MaaT Pharma
1 day | +1.08% | ||
1 week | +1.08% | ||
Current month | +1.08% | ||
1 month | -1.67% | ||
3 months | +33.90% | ||
6 months | +11.90% | ||
Current year | +34.67% |
Managers | Title | Age | Since |
---|---|---|---|
Hervé Affagard
FOU | Founder | - | 13-12-31 |
Siân Crouzet
DFI | Director of Finance/CFO | - | 15-12-31 |
Chief Tech/Sci/R&D Officer | - | 22-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 54 | 13-12-31 | |
Claude Bertrand
BRD | Director/Board Member | 61 | 20-07-15 |
Muriel Prudent
BRD | Director/Board Member | - | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-07 | 9.4 | +1.08% | 1 140 |
24-05-06 | 9.3 | -1.06% | 629 |
24-05-03 | 9.4 | +1.95% | 336 |
24-05-02 | 9.22 | -0.86% | 594 |
24-04-30 | 9.3 | -0.64% | 627 |
Real-time Euronext Paris, May 07, 2024 at 11:35 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+34.67% | 116M | |
+9.67% | 106B | |
+0.78% | 104B | |
+6.72% | 23.25B | |
-13.68% | 22.5B | |
-6.64% | 18.7B | |
-37.26% | 17.95B | |
-10.87% | 16.99B | |
+7.92% | 14.26B | |
+39.11% | 12.76B |
- Stock Market
- Equities
- MAAT Stock